Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 130.
6/28/2019 • Senate
Summary
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act
This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.
The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
Reported to Senate • 6/28/2019
Topics & Subjects
CBO Cost Estimates (1)
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
Sponsor
Cosponsors (1)
Bill Journey
Originated in the Senate
Introduced
April 29, 2019
Committee Review
June 27, 2019
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law